World Equity Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$386K Buy
16,025
+810
+5% +$21.2K 0.09% 262
2026
Q1
$427K Buy
15,215
+108
+0.7% +$2.88K 0.11% 220
2025
Q4
$376K Sell
15,107
-13,601
-47% -$343K 0.11% 212
2025
Q3
$731K Sell
28,708
-15,107
-34% -$373K 0.17% 124
2025
Q2
$1.06M Sell
43,815
-7,160
-14% -$167K 0.29% 75
2025
Q1
$1.33M Sell
50,975
-38,707
-43% -$1.01M 0.38% 59
2024
Q4
$2.37M Buy
89,682
+23,729
+36% +$644K 0.51% 44
2024
Q3
$1.91M Buy
65,953
+8,190
+14% +$239K 0.69% 34
2024
Q2
$1.62M Sell
57,763
-44,349
-43% -$1.22M 0.48% 54
2024
Q1
$2.83M Buy
102,112
+21,148
+26% +$587K 0.58% 41
2023
Q4
$2.76M Buy
80,964
+8,126
+11% +$246K 0.55% 41
2023
Q3
$2.42M Buy
72,838
+37,655
+107% +$1.33M 0.5% 45
2023
Q2
$1.29M Sell
35,183
-101,481
-74% -$3.95M 0.38% 69
2023
Q1
$3.51M Buy
136,664
+97,553
+249% +$4.21M 0.52% 44
2022
Q4
$2M Buy
39,111
+782
+2% +$37.5K 0.48% 60
2022
Q3
$1.68M Buy
38,329
+1,083
+3% +$52.6K 0.42% 61
2022
Q2
$1.95M Sell
37,246
-6,879
-16% -$351K 0.49% 54
2022
Q1
$2.28M Buy
+44,125
New +$2.29M 0.49% 53

Other funds holding PFE

World Equity Group's PFE Position: Q2 2026 in Review

World Equity Group increased its Pfizer (PFE) stake by 5.3% in Q2 2026, buying an estimated $21.2K and bringing the position to 16,025 shares worth $386K. The position accounts for 0.09% of the portfolio, ranked #262.

World Equity Group first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.51M in Q1 2023. 632 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • World Equity Group held 16,025 shares of Pfizer worth $386K as of Q2 2026.
  • World Equity Group bought 810 Pfizer shares in Q2 2026, an estimated $21.2K.
  • Pfizer made up 0.09% of World Equity Group's portfolio in Q2 2026, its #262 holding.
  • World Equity Group first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • World Equity Group's Pfizer position peaked at $3.51M in Q1 2023.
  • 632 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on World Equity Group's 13F filing for Q2 2026, filed 9 Jul 2026.